Navigation Links
Insmed to Host First Quarter 2009 Conference Call
Date:4/23/2009

ase, including statements relating to planned clinical study design, regulatory and business strategies, plans and objectives of management and growth opportunities for existing or proposed products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of product candidates, the FDA may interpret the results of studies differently than us, competing products may be more successful, demand for new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends, our continuing efforts to develop IPLEX(TM) may be unsuccessful our common stock could be delisted from the Nasdaq Capital Market and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2008. Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

    Investor Relations Contact:
    Brian Ritchie - FD
    212-850-5683
    brian.ritchie@fd.com

    Media Contact:
    Irma Gomez-Dib - FD
    212-850-5761
    Irma.gomez-dib@fd.com


'/>"/>
SOURCE Insmed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)
2. Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule
3. Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results
4. Insmed to Host Fourth Quarter and Full-Year 2008 Conference Call
5. Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
6. Insmed to Present at Sanford C. Bernstein Biosimilars Long View Conference
7. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008
8. NASDAQs Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmeds Compliance Date to March 20, 2009
9. Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule
10. Insmed to Seek Shareholder Approval for Reverse Split
11. Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Md. (PRWEB) August 19, 2014 ... liquid chromatography systems, Prominence-i and Nexera-i, adding to ... systems. Combining excellent functionality, an intuitive operating environment, ... and a more efficient workflow for conventional to ... feature innovative, intuitive and intelligent design so users ...
(Date:8/19/2014)... (PRWEB) August 19, 2014 ... to raise $200,000 to fund a corporate lab ... , This development is a critical component ... of care to the implementation of personalized medicine ... of practicing medicine. , Indiegogo contributions will support ...
(Date:8/19/2014)... XenoTech announces an exclusive partnership with ... from bioactive small molecules. Based on an ... convenient and timely assessment of critical metabolite and ... of Commercial Operations, Christian Darabant, “the value of ... be measured directly by comparison with the approximate ...
(Date:8/19/2014)... In November 2012, the European Union (EU) mandated use ... a new PSUR – responding to the increasing need to ... drug. Adopted in many regions, the main objectives of the ... and critical analysis of new or emerging information on the ... evidence of the potential benefits of a drug; and , ...
Breaking Biology Technology:Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 3Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 3Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 2Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 3Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2
... the leading,management consulting firm specializing in the pharmaceutical ... been appointed Chief,Operating Officer. His former role at ... the firm,s Brand Management Practice will be assumed,by ... new senior executive management role for Mr. Naeymi-Rad ...
... the leading,management consulting firm specializing in the pharmaceutical ... been appointed Senior,Vice President and head of the ... who was recently promoted to Chief,Operating Officer at ... member of the Brand Management Practice,since joining the ...
... 7 /PRNewswire-FirstCall/ - Ondine Biopharma Corporation,(TSX: OBP; ... products, today announced that the results of ... to,eliminate Pseudomonas aeruginosa will be published in ... article has been e-published ahead of the ...
Cached Biology Technology:Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance 2Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance 3Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance 2Ondine Announces Publication of Positive Results from Pseudomonas aeruginosa Eradication Study 2Ondine Announces Publication of Positive Results from Pseudomonas aeruginosa Eradication Study 3
(Date:8/19/2014)... born with neonatal abstinence syndrome (NAS) secondary to ... going through withdrawal than others, but the underlying ... epigenetic (when genes are turned on or off) ... researchers at Boston University School of Medicine (BUSM) ... of its kind study to identify some of ...
(Date:8/19/2014)... of today,s crocodiles colonised the seas during warm phases ... new Anglo-French study which establishes a link between marine ... a period of more than 140 million years. ... the Universit de Lyon, France and formerly from the ... Nature Communications ., Today, crocodiles are ,cold-blooded, animals ...
(Date:8/19/2014)... San Antonio and The University of Texas at San ... $750,000 in grants through the San Antonio Life Sciences ... is a model of how a general academic institution ... for greater research and graduate education. , The Innovation ... health issues and diseases of global impact. Funding will ...
Breaking Biology News(10 mins):In-utero methadone, Subutex exposure could alter gene expression, cause severe Neonatal Abstience Syndrome 2Evolution of marine crocodilians constrained by ocean temperatures 2San Antonio Life Sciences Institute awards $750,000 to innovators 2San Antonio Life Sciences Institute awards $750,000 to innovators 3
... techniques of computer engineering to a mechanistic diagram describing ... of researchers in Switzerland has been able to tease ... the crucial cross-talk between cellular signaling pathways takes place ... The novel in silico model is described in a ...
... Cancer Institute have shown in a laboratory study that ... the damage caused by a form of muscular dystrophy. ... and Development, the researchers demonstrated that manipulating a genetic ... mice with Duchenne muscular dystrophy, slowing the disease-associated muscle ...
... new vaccine delivery system using microspheres of a biodegradable polymer ... some cases, but also appears to stimulate an immune response ... University report their findings today at the ASM Biodefense and ... producing antibodies that block entry into the cell. In ...
Cached Biology News:Executable biology -- Computer science sheds light on animal development 2Switching genes to overdrive improves muscular dystrophy symptoms in mice 2Biodegradable microspheres deliver time release vaccines, stimulate different immune response 2
... coli strain containing an overproducing clone of ... Transcriptase catalyzes the polymerization of DNA using ... copies of large mRNAs, >10 kb, may ... much lower RNase H activity than AMV ...
... coli containing a clone of the human Topoisomerase ... II alters the topological state of nucleic acids ... transient break which generates a separate DNA helix ... DNA passage mechanism, the enzyme can relax negatively ...
... Type Liquid. In 100 mM KCl, ... EDTA, 20% glycerol, pH 7.9. AVOID FREEZE/THAW CYCLES. ... monomeric protein of 765 amino acids encoded by ... both positive and negative supercoiled DNAs without the ...
Request Info...
Biology Products: